Manabu Natsumeda

Gene expression signature‐based prognostic risk score in patients with glioblastoma

Atsushi Kawaguchi, Naoki Yajima, Naoto Tsuchiya et al. · Cancer Science · 2013 · 91 citations · Full text

Prognosis, Pathology, High-grade Gliomas +18

Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells

Ulf D. Kahlert, Abigail K. Suwala, Katharina Koch et al. · Journal of Neuropathology & Experimental Neurology · 2015 · 71 citations · Full text

High-grade Gliomas, Cancer Biology, Glioma +19

Immunohistochemical profiles of I<scp>DH</scp>1, <scp>MGMT</scp> and <scp>P</scp>53: Practical significance for prognostication of patients with diffuse gliomas

Ryosuke Ogura, Yoshihiro Tsukamoto, Manabu Natsumeda et al. · Neuropathology · 2015 · 67 citations

The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma

Hiroaki Miyahara, Sridevi Yadavilli, Manabu Natsumeda et al. · Cancer Letters · 2017 · 67 citations · Full text

Glioma, Radiation Therapy, Medicine +9

Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy

Yu Kanemaru, Manabu Natsumeda, Masayasu Okada et al. · Acta Neuropathologica Communications · 2019 · 66 citations · Full text